Physician profile
Steven E Kelley
NPI 1922069103
$116,484.32
in general payments reported to CMS, 2019-2025
28 companies · $36K in 2025
The $36K reported for 2025 was more than what 95% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,304 · 2020: $279 · 2021: $1,279 · 2022: $1,874 · 2023: $18K · 2024: $55K · 2025: $36K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $79K · Travel and Lodging: $16K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,400 · Food and Beverage: $5,465.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $79,375.00 |
| Travel and Lodging | $15,508.46 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,400.00 |
| Food and Beverage | $5,464.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $109,381.02 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $1,945.74 | 2019-2025 | Cardiomems, Thoratec Heartmate 3 Lvas Implant Kit |
| Medtronic, INC. | $1,293.31 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Evera Mri Xt Dr Surescan |
| Shockwave Medical, INC | $702.74 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Boston Scientific Corporation | $614.79 | 2019-2025 | General - Balloon Catheters, Bodyguardian |
| Novartis Pharmaceuticals Corporation | $458.28 | 2019-2025 | |
| Abiomed | $420.09 | 2023-2025 | Impella |
| Merck Sharp & Dohme LLC | $210.58 | 2021-2025 | Verquvo |
| Amgen INC. | $206.09 | 2019-2022 | |
| Angiodynamics, INC. | $191.84 | 2024 | Auryon Laser System 100-120 Vac |
| Irhythm Technologies, INC. | $148.08 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Janssen Pharmaceuticals, INC | $131.75 | 2019-2023 | Xarelto |
| Kestra Medical Technology Services, INC. | $115.62 | 2023-2025 | Assure Wcd |
| Alnylam Pharmaceuticals INC. | $95.21 | 2024-2025 | Onpattro |
| Astrazeneca Pharmaceuticals Lp | $85.08 | 2021-2023 | Farxiga |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $66.81 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $52.97 | 2021-2025 | Eliquis, Camzyos |
| Baxter Healthcare | $48.55 | 2023 | Hillrom - Carnation Ambulatory Monitor |
| Silk Road Medical, INC. | $46.54 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Esperion Therapeutics, INC. | $40.23 | 2021-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.37 | 2023-2024 | Lifevest |
| Itamar Medical INC | $37.06 | 2025 | Watchpatone |
| Cardiovascular Systems INC. | $34.27 | 2022 | |
| Novo Nordisk INC | $33.38 | 2024-2025 | Wegovy |
| Impulse Dynamics (USA) INC. | $28.30 | 2023 | Optimizer |
| Cardiva Medical, INC. | $23.28 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $18.04 | 2024 | Arcalyst |
| Arbor Pharmaceuticals, INC. | $15.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kelley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.